Focusing on Solid Dosage Trends and Demand
Webinar Date/Time: Fri, Nov 22, 2024 11:00 AM EST
Find out more about key trends shaping solid dosage drug development and manufacturing and the changing demands impacting the market. Furthermore, gain a greater understanding about how coating design has evolved over the years and how regulatory requirements are affecting solid dosage developers and manufacturers.
Register Free: https://www.pharmtech.com/pt_w/solid-dosage-trends
Event Overview:
In this exclusive Drug Digest video interview, Felicity Thomas, Associate Editorial Director, Pharmaceutical Technology Group, interviews experts about solid dosage drug development and manufacturing. During the discussion, expert(s) will provide an overview of the solid dosage drug development and manufacturing sector, factors driving growth in the market, challenges facing companies and the shifts in demand, the evolution of coating design, and regulatory considerations impacting oral solid dosage development and manufacturing.
Key learning Objectives:
- Learning about trends shaping the solid dosage drug development and manufacturing market
- Understanding the challenges facing solid dosage development and manufacturing
- Learning about the changing demand within the solid dosage development and manufacturing field
- Highlighting the evolution of coating design for oral solid dosage forms
- Discovering regulatory requirements impacting oral solid dosage development and manufacturing
Who Should Attend:
- Solid dosage drug developers
- Solid dosage drug manufacturers
- Formulation scientists
- Quality personnel
- CDMOs
- Development scientists
Speaker:
Dr. Ali Rajabi-Siahboomi
Vice President and Chief Innovation Officer
Colorcon
Ali Rajabi-Siahboomi is the vice president and chief innovation officer at Colorcon, based at the Global Headquarter, USA. Rajabi-Siahboomi has held various academic positions in Nottingham and Liverpool JM Universities in the UK before joining Colorcon as technical director, responsible for Europe, the Middle East, and Africa in 2000. His main research interests are solid dosage form pharmaceutics, pharmaceutical technology with emphasis on oral drug delivery systems, solubility enhancement to improve bioavailability, and consistency of drugs and bioequivalence formulations. He has published more than 300 articles, book chapters, abstracts, and patents and obtained his B.Pharm. and PhD in pharmacy from the University of Nottingham (UK).
Register Free: https://www.pharmtech.com/pt_w/solid-dosage-trends
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
How Smart Technology is Helping Reach Sustainability Goals in Drug Packaging
June 7th 2025Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers align with sustainability goals, according to Sheikh Akbar Ali, general manager and head of Development and Technology for ACG Packaging Materials.
